[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,079,911
  • Shares Outstanding, K 50,866
  • Annual Sales, $ 534,530 K
  • Annual Income, $ -11,450 K
  • EBIT $ 3 M
  • EBITDA $ 12 M
  • 60-Month Beta 1.24
  • Price/Sales 3.78
  • Price/Cash Flow 127.00
  • Price/Book 3.92

Options Overview Details

View History
  • Implied Volatility 53.04% (-3.96%)
  • Historical Volatility 53.45%
  • IV Percentile 8%
  • IV Rank 21.45%
  • IV High 114.53% on 03/30/26
  • IV Low 36.25% on 08/18/25
  • Expected Move (DTE 21) 1.72 (4.28%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 76
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 841
  • Open Int (30-Day) 1,957
  • Expected Range 38.43 to 41.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.04
  • Number of Estimates 2
  • High Estimate $0.01
  • Low Estimate $-0.08
  • Prior Year $-0.01
  • Growth Rate Est. (year over year) -300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.20 +42.38%
on 07/01/26
41.29 -2.76%
on 07/29/26
+12.17 (+43.50%)
since 06/30/26
3-Month
25.36 +58.32%
on 06/02/26
41.29 -2.76%
on 07/29/26
+12.04 (+42.83%)
since 04/30/26
52-Week
25.36 +58.32%
on 06/02/26
43.18 -7.02%
on 01/08/26
+5.02 (+14.29%)
since 07/30/25

Most Recent Stories

More News
AtriCure to Participate at Upcoming Investor Conferences

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.15 (-1.81%)
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive...

INSP : 50.02 (-2.06%)
ATRC : 40.15 (-1.81%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 40.15 (-1.81%)
AtriCure Reports Second Quarter 2026 Financial Results

Second Quarter 2026 worldwide revenue of $153.6 million, an increase of 12.8% year over year Second Quarter 2026 profitability strengthened, with net income of $9.0 million and adjusted...

ATRC : 40.15 (-1.81%)
AtriCure's Afib Device Approval Could Redefine the Company or Expose How Narrow the Market Really Is

Barchart Research What to Expect from ATRC Earnings ATRC Generated July 22, 2026 Current Price $33.52 EPS Estimate $$0.03 Consensus Rating Moderate Buy Average Move 8.17% AtriCure's Afib Device Approval...

ATRC : 40.15 (-1.81%)
AtriCure to Announce Second Quarter 2026 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.15 (-1.81%)
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.15 (-1.81%)
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook

AtriCure (NASDAQ:ATRC) executives said the company’s 2026 revenue outlook is being supported by recent and upcoming product launches, continued adoption of its EnCompass ablation platform and expanding...

ATRC : 40.15 (-1.81%)
AtriCure Reports First Quarter 2026 Financial Results

First Quarter 2026 worldwide revenue of $141.2 million, an increase of 14.3% year over year First Quarter 2026 profitability improved, with net income of $0.1 million and adjusted EBITDA...

ATRC : 40.15 (-1.81%)
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.15 (-1.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 42.23
2nd Resistance Point 41.70
1st Resistance Point 40.92
Last Price 40.15
1st Support Level 39.61
2nd Support Level 39.08
3rd Support Level 38.30

See More

52-Week High 43.18
Last Price 40.15
Fibonacci 61.8% 36.37
Fibonacci 50% 34.27
Fibonacci 38.2% 32.17
52-Week Low 25.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.